Alnylam Pharmaceuticals (ALNY) Short Interest Ratio & Short Volume $246.27 -2.89 (-1.16%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Alnylam Pharmaceuticals Short Interest DataAlnylam Pharmaceuticals (ALNY) has a short interest of 3.35 million shares. This marks a -4.01% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.4, indicating that it would take 4.4 days of the average trading volume of 504,065 shares to cover all short positions.Current Short Interest3,350,000 sharesPrevious Short Interest3,490,000 sharesChange Vs. Previous Month-4.01%Dollar Volume Sold Short$788.29 millionShort Interest Ratio4.4 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares128,980,000 sharesPercentage of Shares Shorted2.60%Today's Trading Volume556,461 sharesAverage Trading Volume504,065 sharesToday's Volume Vs. Average110% Short Selling Alnylam Pharmaceuticals? Sign up to receive the latest short interest report for Alnylam Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartALNY Short Interest Over TimeALNY Days to Cover Over TimeALNY Percentage of Float Shorted Over Time Alnylam Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/20243,350,000 shares $788.29 million -4.0%N/A4.4 $235.31 12/15/20243,490,000 shares $856.59 million +3.0%N/A4.5 $245.44 11/30/20243,390,000 shares $857.91 million -9.4%N/A4.4 $253.07 11/15/20243,740,000 shares $880.99 million +1.1%N/A4.3 $235.56 10/31/20243,700,000 shares $986.38 million -23.6%N/A4.6 $266.59 10/15/20244,840,000 shares $1.39 billion +7.3%N/A5.8 $287.36 9/30/20244,510,000 shares $1.24 billion +1.4%N/A5.5 $275.03 9/15/20244,450,000 shares $1.18 billion +18.0%N/A3.8 $265.27 8/31/20243,770,000 shares $990.34 million -16.6%N/A3.1 $262.69 8/15/20244,520,000 shares $1.19 billion +4.4%N/A4 $262.70 Get the Latest News and Ratings for ALNY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alnylam Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/31/20244,330,000 shares $1.03 billion -3.6%N/A4 $237.46 7/15/20244,490,000 shares $1.15 billion +22.0%N/A4.5 $256.18 6/30/20243,680,000 shares $894.24 million +72.8%N/A3.9 $243.00 6/15/20242,130,000 shares $341.63 million -14.1%N/A2.6 $160.39 5/31/20242,480,000 shares $368.11 million -2.4%N/A4.4 $148.43 5/15/20242,540,000 shares $374.40 million -3.4%N/A4.3 $147.40 4/30/20242,630,000 shares $378.59 million +5.2%N/A3.2 $143.95 4/15/20242,500,000 shares $369.25 million -10.7%N/A3 $147.70 3/31/20242,800,000 shares $418.46 million +4.1%N/A3.3 $149.45 3/15/20242,690,000 shares $401.54 million -11.5%N/A3.2 $149.27 2/29/20243,040,000 shares $459.31 million -23.8%N/A3.6 $151.09 2/15/20243,990,000 shares $588.25 million -0.5%N/A5 $147.43 1/31/20244,010,000 shares $693.37 million -7.4%N/A6.5 $172.91 1/15/20244,330,000 shares $837.38 million -8.5%N/A7.4 $193.39 12/31/20234,730,000 shares $905.37 million -5.2%N/A7.6 $191.41 12/15/20234,990,000 shares $924.35 million -2.0%N/A7.8 $185.24 11/30/20235,090,000 shares $856.39 million -1.9%N/A7.6 $168.25 11/15/20235,190,000 shares $887.75 million -1.5%N/A8 $171.05 10/31/20235,270,000 shares $799.99 million -1.7%N/A8.3 $151.80 10/15/20235,360,000 shares $901.12 million +3.9%N/A8.7 $168.12 9/30/20235,160,000 shares $913.84 million +0.2%N/A8.6 $177.10 9/15/20235,150,000 shares $952.70 million -2.8%N/A9 $184.99 8/31/20235,300,000 shares $1.05 billion -1.5%N/A9.9 $197.82 8/15/20235,380,000 shares $969.10 million +1.7%N/A10.2 $180.13 7/31/20235,290,000 shares $1.03 billion +6.9%N/A9.7 $195.40 7/15/20234,950,000 shares $975.65 million -0.6%N/A8.4 $197.10 6/30/20234,980,000 shares $945.90 million +0.4%N/A8 $189.94 6/15/20234,960,000 shares $1.00 billion -1.8%N/A7.4 $202.34 5/31/20235,050,000 shares $934.30 million -1.4%N/A7 $185.01 5/15/20235,120,000 shares $1.06 billion +0.8%N/A6.3 $206.20URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now 4/30/20235,080,000 shares $1.01 billion +2.2%N/A6.2 $199.20 4/15/20234,970,000 shares $1.01 billion -4.1%N/A6 $203.92 3/31/20235,180,000 shares $1.04 billion +5.1%N/A6.4 $200.32 3/15/20234,930,000 shares $915.75 million -8.5%N/A6.3 $185.75 2/28/20235,390,000 shares $1.03 billion +5.7%N/A7 $191.45 2/15/20235,100,000 shares $1.13 billion -4.3%N/A6.5 $222.10 1/31/20235,330,000 shares $1.21 billion -6.2%N/A7.1 $226.40 1/15/20235,680,000 shares $1.34 billion +11.2%N/A7.3 $235.53 12/30/20225,110,000 shares $1.21 billion -5.4%N/A6.2 $237.65 12/15/20225,400,000 shares $1.24 billion +8.2%N/A6.1 $229.37 11/30/20224,990,000 shares $1.10 billion -10.3%N/A5.1 $220.59 11/15/20225,560,000 shares $1.19 billion -7.8%N/A5.7 $214.29 10/31/20226,030,000 shares $1.25 billion +25.6%N/A6.1 $207.26 10/15/20224,800,000 shares $890.54 million +5.7%N/A4.2 $185.53 9/30/20224,540,000 shares $908.73 million +3.7%N/A4.2 $200.16 9/15/20224,380,000 shares $913.14 million +4.3%N/A4.2 $208.48 8/31/20224,200,000 shares $868.01 million -16.0%N/A4 $206.67 8/15/20225,000,000 shares $1.16 billion +1.4%N/A5.2 $231.01 7/31/20224,930,000 shares $700.26 million -1.2%N/A4.9 $142.04 7/15/20224,990,000 shares $725.50 million +4.2%N/A5.8 $145.39 6/30/20224,790,000 shares $698.62 million +1.1%N/A5.5 $145.85 6/15/20224,740,000 shares $642.03 million -15.7%5.0%5.4 $135.45 5/31/20225,620,000 shares $707.00 million -4.1%N/A6.8 $125.80 5/15/20225,860,000 shares $741.11 million -1.0%N/A6.7 $126.47 4/30/20225,920,000 shares $789.91 million +2.3%N/A7 $133.43 4/15/20225,790,000 shares $968.90 million +11.8%N/A7.1 $167.34 3/31/20225,180,000 shares $845.84 million +9.5%N/A6.4 $163.29 3/15/20224,730,000 shares $723.31 million +3.7%N/A5.4 $152.92 2/28/20224,560,000 shares $719.80 million +3.9%N/A5.2 $157.85 2/15/20224,390,000 shares $672.99 million +8.1%N/A5.3 $153.30 1/31/20224,060,000 shares $558.66 million +2.8%3.6%5.1 $137.60 1/15/20223,950,000 shares $586.58 million +11.9%N/A4.8 $148.50 12/31/20213,530,000 shares $598.62 million -6.1%N/A4.6 $169.58 12/15/20213,760,000 shares $718.39 million -4.8%N/A5.1 $191.06 11/30/20213,950,000 shares $726.01 million -2.5%N/A6.5 $183.80 11/15/20214,050,000 shares $701.91 million +4.9%N/A6.8 $173.31 10/29/20213,860,000 shares $615.90 million -0.5%N/A6.4 $159.56 10/15/20213,880,000 shares $809.21 million -3.2%N/A7.1 $208.56 9/30/20214,010,000 shares $757.13 million -9.3%N/A6.7 $188.81 9/15/20214,420,000 shares $828.66 million -8.5%N/A7 $187.48 8/31/20214,830,000 shares $972.91 million -3.6%N/A7.2 $201.43 8/13/20215,010,000 shares $984.67 million -1.0%N/A7.3 $196.54 7/30/20215,060,000 shares $905.44 million +19.9%N/A7.7 $178.94 7/15/20214,220,000 shares $725.63 million -2.3%3.6%6.8 $171.95 6/30/20214,320,000 shares $732.33 million -6.7%3.7%7.2 $169.52 6/15/20214,630,000 shares $770.90 million +9.2%4.0%8.7 $166.50 5/28/20214,240,000 shares $602.04 million -6.2%3.7%8.6 $141.99 5/14/20214,520,000 shares $600.80 million +9.4%N/A9.1 $132.92 4/30/20214,130,000 shares $576.92 million +0.7%N/A7.7 $139.69 4/15/20214,100,000 shares $567.07 million +12.3%N/A7 $138.31URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now 3/31/20213,650,000 shares $493.22 million -1.9%N/A5.3 $135.13 3/15/20213,720,000 shares $528.98 million +0.5%N/A5.2 $142.20 2/26/20213,700,000 shares $542.38 million +5.1%N/A5.4 $146.59 2/12/20213,520,000 shares $582.14 million -4.9%N/A5.2 $165.38 1/29/20213,700,000 shares $572.54 million -4.4%N/A5.4 $154.74 1/15/20213,870,000 shares $638.82 million +10.9%N/A5.9 $165.07 12/31/20203,490,000 shares $457.33 million -4.6%N/A6.4 $131.04 12/15/20203,660,000 shares $485.65 million -3.2%N/A7.2 $132.69 11/30/20203,780,000 shares $490.87 million +1.3%N/A7.4 $129.86 11/15/20203,730,000 shares $505.45 million +3.9%N/A7.2 $135.51 10/30/20203,590,000 shares $442.72 million +5.9%N/A7.5 $123.32 10/15/20203,390,000 shares $487.85 million +4.0%N/A7.3 $143.91 9/30/20203,260,000 shares $474.66 million -9.2%N/A6.6 $145.60 9/15/20203,590,000 shares $468.53 million -10.7%N/A6.2 $130.51 8/31/20204,020,000 shares $533.21 million -5.6%N/A6.1 $132.64 8/14/20204,260,000 shares $579.96 million No ChangeN/A6.2 $136.14 7/31/20204,260,000 shares $620.94 million -9.9%N/A5.7 $145.76 7/15/20204,730,000 shares $747.43 million -13.1%N/A5.8 $158.02 6/30/20205,440,000 shares $804.63 million -7.0%N/A6.2 $147.91 6/15/20205,850,000 shares $751.02 million +11.9%N/A6.9 $128.38 5/29/20205,230,000 shares $707.46 million +0.6%N/A6.1 $135.27 5/15/20205,200,000 shares $724.26 million +2.4%N/A6 $139.28 4/30/20205,080,000 shares $668.68 million -5.1%N/A5.9 $131.63 4/15/20205,350,000 shares $650.03 million +9.2%N/A6.4 $121.50 3/31/20204,900,000 shares $713.59 million +0.9%N/A6.2 $145.63 3/13/20204,855,400 shares $565.07 million -4.6%N/A6.9 $116.38 2/28/20205,090,000 shares $504.22 million +0.2%N/A7.6 $99.06 2/14/20205,080,000 shares $555.70 million +1.2%N/A7.1 $109.39 1/31/20205,020,000 shares $592.61 million +4.6%4.5%6.8 $118.05 ALNY Short Interest - Frequently Asked Questions What is Alnylam Pharmaceuticals' current short interest? Short interest is the volume of Alnylam Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of December 31st, investors have sold 3,350,000 shares of ALNY short. Learn More on Alnylam Pharmaceuticals' current short interest. What is a good short interest ratio for Alnylam Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALNY shares currently have a short interest ratio of 4.0. Learn More on Alnylam Pharmaceuticals's short interest ratio. Which institutional investors are shorting Alnylam Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Alnylam Pharmaceuticals: Portman Square Capital LLP, Barclays PLC, Jane Street Group LLC, Wolverine Trading LLC, Parallax Volatility Advisers L.P., Melqart Asset Management UK Ltd, Cinctive Capital Management LP, Paloma Partners Management Co, Garda Capital Partners LP, Walleye Trading LLC, Walleye Capital LLC, PEAK6 Investments LLC, Citigroup Inc., and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Alnylam Pharmaceuticals' short interest increasing or decreasing? Alnylam Pharmaceuticals saw a drop in short interest in December. As of December 31st, there was short interest totaling 3,350,000 shares, a drop of 4.0% from the previous total of 3,490,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Alnylam Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "biotechnology" compare to Alnylam Pharmaceuticals: Gilead Sciences, Inc. (2.07%), Vertex Pharmaceuticals Incorporated (1.54%), Regeneron Pharmaceuticals, Inc. (1.91%), Biogen Inc. (2.54%), United Therapeutics Co. (4.38%), Neurocrine Biosciences, Inc. (3.31%), Incyte Co. (2.69%), BioMarin Pharmaceutical Inc. (2.38%), Exact Sciences Co. (5.78%), Exelixis, Inc. (3.75%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Alnylam Pharmaceuticals stock? Short selling ALNY is an investing strategy that aims to generate trading profit from Alnylam Pharmaceuticals as its price is falling. ALNY shares are trading down $2.89 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Alnylam Pharmaceuticals? A short squeeze for Alnylam Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ALNY, which in turn drives the price of the stock up even further. How often is Alnylam Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALNY, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies Gilead Sciences Short Interest Vertex Pharmaceuticals Short Interest Regeneron Pharmaceuticals Short Interest Biogen Short Interest United Therapeutics Short Interest Neurocrine Biosciences Short Interest Incyte Short Interest BioMarin Pharmaceutical Short Interest Exact Sciences Short Interest Exelixis Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ALNY) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBitcoin to $200K?Newsweek recently asked several analysts whether they think Bitcoin will hit $200,000 by the end of 2025. T...Stansberry Research | SponsoredElon's "Final Move" Could Send This Stock SoaringWhenever Elon Musk starts a new venture... Early investors get the opportunity to become millionaires... ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alnylam Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alnylam Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALNY Stock Alerts